中文版
Anti-Cancer (Oncology)
Temsirolimus (CCI-779)
Catalog No. :
CL1066
Product Name :
Temsirolimus (CCI-779)
CAS No. :
162635-04-3
Synonyms :
CCI-779
Chemical Name :
(1R,2R,4S)-4-{(2R)-2-[(3S,6R,7E,9R,10R,12R,14S,15E,17E,19E,21S,23S,26R,27R,34aS)-9,27-dihydroxy-10,21-dimethoxy-6,8,12,14,20,26-hexamethyl-1,5,11,28,29-pentaoxo-1,4,5,6,9,10,11,12,13,14,21,22,23,24,25,26,27,28,29,31,32,33,34,34a-tetracosahydro-3H-23,27-epoxypyrido[2,1-c][1,4]oxazacyclohentriacontin-3-yl]propyl}-2-methoxycyclohexyl 3-hydroxy-2-(hydroxymethyl)-2-methylpropanoate.
Molecular Formula :
C56H87NO16
Molecular Weight :
1030.29
Molecular Structure :
Appearance :
White to off-white powder
Specification :
98+%
Application :
mTOR inhibitor | Autophagy activator | Apoptosis related activator
Registration :
Storage Condition :
Dry, dark and at 0 - 4 ℃ for short term (days to weeks) or -20 ℃ for long term (months to years).

Temsirolimus is a specific mTOR inhibitor with IC50 of 1.76 μM in a cell-free assay. Temsirolimus induces autophagy and apoptosis.

Statement:
->>Products covered by valid patents are not offered or supplied for commercial use.
->>Products currently covered by valid US Patents are offered for laboratory R&D use in accordance with 35 USC 271(e)+A13(1).
->>Any patent infringement and resulting liability is solely at buyer's risk.
->>Our products are only raw materials for drugs or industry, can't be used for human or animals directly.

Request A Quote
Your Name(required)
Email(required)
Product Name(required)
Country or Region(required)
Organization Name(required)
Messages(required)
Captcha(required)
Sending...